North Dakota State Investment Board Buys New Stake in Tenet Healthcare Corporation $THC

North Dakota State Investment Board bought a new stake in shares of Tenet Healthcare Corporation (NYSE:THC) during the 4th quarter, Holdings Channel.com reports. The firm bought 3,066 shares of the company’s stock, valued at approximately $609,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Triumph Capital Management bought a new stake in shares of Tenet Healthcare during the 3rd quarter valued at about $25,000. Activest Wealth Management bought a new position in shares of Tenet Healthcare in the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare during the fourth quarter valued at approximately $29,000. Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare during the second quarter valued at approximately $35,000. Finally, Westside Investment Management Inc. lifted its position in shares of Tenet Healthcare by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after acquiring an additional 96 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on THC shares. KeyCorp dropped their price objective on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Morgan Stanley set a $254.00 price target on shares of Tenet Healthcare in a research report on Friday, May 1st. Robert W. Baird cut their price target on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. Finally, Wall Street Zen downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Nineteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $244.16.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, EVP Paola M. Arbour sold 6,500 shares of the stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the sale, the executive vice president directly owned 29,291 shares in the company, valued at $6,983,853.13. This represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Thomas W. Arnst sold 24,000 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the sale, the executive vice president owned 8,012 shares in the company, valued at $1,875,128.48. The trade was a 74.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 46,517 shares of company stock worth $10,943,111 over the last ninety days. Insiders own 0.97% of the company’s stock.

Tenet Healthcare Stock Performance

Shares of THC opened at $177.96 on Friday. The firm’s 50 day moving average price is $195.29 and its two-hundred day moving average price is $203.09. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. The firm has a market cap of $15.33 billion, a P/E ratio of 9.25, a PEG ratio of 1.24 and a beta of 1.30. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the previous year, the firm posted $4.36 earnings per share. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, analysts forecast that Tenet Healthcare Corporation will post 17.64 EPS for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.